Prokidney PROK
NASDAQ PROK
$1.85 -0.14 (-7.04%)
At close: Sep 9, 2026 · 4:00 PM EDT

Prokidney (PROK) Retained Earnings (2021 - 2026)

Prokidney's (PROK) quarterly Retained Earnings came in at -$1.3 billion in Q2 2026, down 6.82% year-over-year from -$1.4 billion in Q2 2025, and down 2.2% quarter-over-quarter from -$1.3 billion in Q1 2026.

Analysis

Prokidney (PROK) Retained Earnings (2021 - 2026) Analysis & Trends

Prokidney (PROK) has reported Retained Earnings for 6 consecutive years, with -$1.3 billion the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Retained Earnings fell 6.82% year-over-year to -$1.3 billion in Q2 2026; TTM through Jun 2026 was -$1.3 billion, a 6.82% decrease from a year earlier, with the FY2025 full-year figure at -$1.3 billion, down 5.74% from the prior year.
  • Retained Earnings was -$1.3 billion for Q2 2026 at Prokidney, down from -$1.3 billion in the prior quarter.
  • Over five years, Retained Earnings peaked at -$12.4 million in Q1 2022 and troughed at -$1.6 billion in Q1 2023.
  • A 5-year average of -$1.1 billion and a median of -$1.2 billion in 2024 frame the typical range for Retained Earnings.
  • Across the five-year window, Retained Earnings tumbled 61667.36% in 2022 and rose 29.21% in 2024, its largest moves.
  • Over 5 years, Retained Earnings stood at -$1.1 billion in 2022, then fell by 3.22% to -$1.1 billion in 2023, then fell by 5.37% to -$1.2 billion in 2024, then retreated by 5.74% to -$1.3 billion in 2025, then fell by 3.82% to -$1.3 billion in 2026.
  • The last three Retained Earnings figures came in at -$1.3 billion (Q2 2026), -$1.3 billion (Q1 2026), and -$1.3 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn 1.23 Bn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn - -2.16 Bn
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn 3.62 Bn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn 1.23 Bn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn 1.84 Bn
6 Beam Therapeutics 2.65 Bn 2.65 Bn - 2.93 Bn
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn 2.37 Bn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn -4.55 Bn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn -380.40 Mn
10 Prokidney 346.07 Mn 346.07 Mn - -1.32 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.32 Bn
Mar 31, 2026 -1.29 Bn
Dec 31, 2025 -1.27 Bn
Sep 30, 2025 -1.25 Bn
Jun 30, 2025 -1.23 Bn
Mar 31, 2025 -1.22 Bn
Dec 31, 2024 -1.20 Bn
Sep 30, 2024 -1.18 Bn
Jun 30, 2024 -1.16 Bn
Mar 31, 2024 -1.15 Bn
Dec 31, 2023 -1.14 Bn
Sep 30, 2023 -1.13 Bn
Jun 30, 2023 -1.35 Bn
Mar 31, 2023 -1.62 Bn
Dec 31, 2022 -1.10 Bn
Sep 30, 2022 -1.10 Bn
Jun 30, 2022 -15.00 Mn
Mar 31, 2022 -12.36 Mn
Dec 31, 2021 -161.51 Mn
Sep 30, 2021 -6.32 Mn